OPEN END TURBO OPTIONSSCHEIN LONG - BECTON DICKINSON AND CO. Share Price

Certificat

DE000GZ0UT77

Real-time BOERSE MUENCHEN 09:56:26 03/06/2024 pm IST
2.92 EUR +28.07% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - BECTON DICKINSON AND CO.
1 month-19.72%
3 months-27.39%
Date Price Change
03/24/03 2.92 +28.07%
31/24/31 2.28 +21.28%
30/24/30 1.88 +1.08%
29/24/29 1.86 -6.06%
28/24/28 1.98 -6.60%

Real-time BOERSE MUENCHEN

Last update June 03, 2024 at 09:56 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Goldman Sachs
WKN GZ0UT7
ISINDE000GZ0UT77
Date issued 28/09/2022
Strike 205.9 $
Maturity Unlimited
Parity 10 : 1
Emission price 4.8
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.51
Lowest since issue 1.65
Spread 0.02
Spread %0.68%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
232 USD
Average target price
278.7 USD
Spread / Average Target
+20.14%
Consensus